The APRIL paradox in normal versus malignant B cell biology

Cell Death Dis. 2016 Jun 23;7(6):e2276. doi: 10.1038/cddis.2016.183.

Authors

M H A van Attekum^{1

2}, A P Kater^{1

3}, E Eldering^{2

3}

Affiliations

¹ Department of Hematology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.
² Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.
³ Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
B-Lymphocytes / metabolism*
B-Lymphocytes / pathology*
CD40 Ligand / metabolism
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
Leukemia, Lymphocytic, Chronic, B-Cell / pathology
Mice, Knockout
Models, Biological
Tumor Necrosis Factor Ligand Superfamily Member 13 / metabolism*

Substances

Tumor Necrosis Factor Ligand Superfamily Member 13
CD40 Ligand